Sensei Biotherapeutics, Inc. announced the appointment of Jessie M. English, Ph.D. to its Board of Directors. She currently serves as the Chief Scientific Officer of Bakx Therapeutics. Previously, she was Chief Scientific Officer of Tilos Therapeutics, which was acquired by Merck in 2019. Dr. English’s expertise spans leadership experience in industry and academic collaborations in oncology drug discovery, establishment of translational programs and development of novel translational platforms.